bioMérieux Company Description
bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests.
The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories.
bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France.
bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
![bioMérieux logo](https://img.stockanalysis.com/logos1/PA/BIM.png)
Country | France |
Founded | 1963 |
Industry | Diagnostics & Research |
Sector | Healthcare |
Employees | 13,982 |
CEO | Pierre Boulud |
Contact Details
Address: 376 Chemin De l’Orme Marcy-l'Étoile, 69280 France | |
Phone | 33 4 78 87 20 00 |
Website | biomerieux.com |
Stock Details
Ticker Symbol | BIM |
Exchange | Euronext Paris |
Fiscal Year | January - December |
Reporting Currency | EUR |
ISIN Number | FR0013280286 |
SIC Code | 2835 |
Key Executives
Name | Position |
---|---|
Pierre Boulud | Chief Executive Officer |
Guillaume Bouhours | Executive Vice President of Purchasing and Information Systems and Chief Financial Officer |
Sylvain Morgeau | Investor Relations |
Audrey Dauvet | Executive Vice President of Legal, Corporate Integrity and Public Affairs |
Valerie Leylde | Executive Vice President of Human Resources, Communications and CSR |
Pierre Charbonnier | Executive Vice President of Global Quality, Manufacturing and Supply Chain |
Yasha Mitrotti | Executive Vice President of Industrial Applications |
Frederic Beseme | Head of CSR |
Jennifer Zinn | Executive Vice President of Clinical Operations |
Dr. Charles K. Cooper | Executive Vice President and Chief Medical Officer |